| | | | | |
| €27,2834 | +0,16 % | €240,59M | €12,22K | |
DBL DOUBLELINE OPPORTUNISTIC CREDIT FUND | €12,0636 | -0,18 % | €240,29M | €33,43K | |
TSI TCW Strategic Income Fund, Inc. | €3,7524 | +0,34 % | €239,90M | €196,57K | |
PAII Pyrophyte Acquisition Corp. II | €8,8043 | +0,05 % | €239,48M | €18,01 | |
| €12,0292 | -4,14 % | €239,36M | €291,20K | |
YDES YD Bio Limited Ordinary Shares | €3,9540 | -1,71 % | €239,36M | €13,07K | |
XCBE X3 Acquisition Corp. Ltd. Class A Ordinary Shares | €8,5719 | +0,04 % | €239,05M | €18,01 | |
RWAY Runway Growth Finance Corp. Common Stock | €5,5965 | -1,73 % | €239,04M | €252,90K | |
JILL J.Jill, Inc. Common Stock | €17,1154 | -1,26 % | €239,03M | €22,44K | |
LCTX Lineage Cell Therapeutics, Inc. | €0,93060 | +0,46 % | €238,61M | €435,90K | |
AXIN Axiom Intelligence Acquisition Corp 1 Class A Ordinary Shares | €8,8437 | +0,01 % | €238,54M | €11,68K | |
ACV Virtus Diversified Income & Convertible Fund | €22,6947 | -0,71 % | €238,52M | €7,45K | |
ALXO ALX Oncology Holdings Inc. Common Stock | €1,7025 | -2,70 % | €238,38M | €153,80K | |
| €1,2136 | -1,05 % | €238,30M | €522,66K | |
YSG Yatsen Holding Limited American Depositary Shares, each representing twenty (20) Class A Ordinary Shares | €2,5688 | -0,17 % | €238,15M | €38,91K | |
